Risk of death with nesiritide [1] (multiple letters)

JAMA

Volumn 294, Issue 8, 2005, Pages 897-898

  Burger, Andrew J ^a   Gortney, Justine Schuller ^b   Porter, Kalen B ^b   Sackner Bernstein, Jonathan D ^c   Aaronson, Keith ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MERCER UNIVERSITY   (United States)

^c NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; NESIRITIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DOBUTAMINE; NATRIURETIC FACTOR; CARDIOTONIC AGENT;

CONFIDENCE INTERVAL; DEATH; DISEASE ASSOCIATION; DRUG INFUSION; HEART DEATH; HUMAN; LETTER; MEDICAL ASSESSMENT; PRIORITY JOURNAL; RANDOMIZATION; RISK ASSESSMENT; RISK FACTOR; RR INTERVAL; CONGESTIVE HEART FAILURE; MORTALITY; NOTE; METHODOLOGY;

ADRENERGIC BETA-ANTAGONISTS; DOBUTAMINE; HEART FAILURE, CONGESTIVE; HUMANS; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; CARDIOTONIC AGENTS; NITROGLYCERIN; RESEARCH DESIGN;

EID: 23944452910     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.294.8.897-b     Document Type: Letter

References (0)